glyoxal has been researched along with pimagedine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kurokawa, K; Mitsuma, T; Miyata, T; Niwa, H; Sobue, G; Takeda, A; Wakai, M; Yasuda, Y | 1 |
| Abordo, EA; Minhas, HS; Thornalley, PJ | 1 |
| Lagarde, M; Lecomte, M; Moinet, G; Patereau, G; Ruggiero-Lopez, D; Wiernsperger, N | 1 |
| Argirov, OK; Thornalley, PJ; Yurek-George, A | 1 |
| Asahi, K; Inagi, R; Izuhara, Y; Kurokawa, K; Miyata, T; Saito, A; Ueda, Y; VAN Ypersele DE Strihou, C | 1 |
| Cervantes-Laurean, D; Jacobson, EL; Jacobson, MK; Kim, M; Qasem, JG; Roberts, MJ; Wondrak, GT | 1 |
| Bellmunt, MJ; Nègre-Salvayre, A; Pamplona, R; Portero-Otín, M; Prat, J; Ruiz, MC; Salvayre, R | 1 |
| Hayase, F; Hayashi, MC; Horiuchi, S; Kinae, N; Masuda, S; Nagai, R; Unno, Y | 1 |
| Funk, RH; Geffarth, R; Kasper, M; Reber, F; Reichenbach, A; Schleicher, ED; Siegner, A | 1 |
| Auge, N; Ayala, V; Cantero, AV; Elbaz, M; Nègre-Salvayre, A; Pamplona, R; Portero-Otín, M; Salvayre, R; Sanson, M; Thiers, JC | 1 |
| Butler, ES; Eubank, TD; Kotha, SR; Kuppusamy, ML; Kuppusamy, P; Marsh, CB; Parinandi, NL; Roy, S; Sherwani, SI; Sliman, SM; Stern, DM | 1 |
| Sparrow, JR; Ueda, K; Yamamoto, K; Yoon, KD; Zhou, J | 1 |
| André-Frei, V; Bechetoille, N; Berthod, F; Cadau, S; Leoty-Okombi, S; Pain, S | 1 |
| Aldini, G; Carini, M; Casali, G; Colzani, M; De Maddis, D; Vistoli, G | 1 |
| Maciejczyk, M; Nesterowicz, M; Zalewska, A; Żendzian-Piotrowska, M; Ładny, JR | 1 |
1 review(s) available for glyoxal and pimagedine
| Article | Year |
|---|---|
Biochemical and Biophysical in Vitro Studies and Systematic Literature Review on the Antioxidant and Antiglycation Activities of Trazodone.
Topics: Advanced Oxidation Protein Products; Antioxidants; Glucose; Glycation End Products, Advanced; Glycosylation; Glyoxal; Molecular Docking Simulation; Serum Albumin, Bovine; Trazodone | 2023 |
14 other study(ies) available for glyoxal and pimagedine
| Article | Year |
|---|---|
Accelerated formation of N epsilon-(carboxymethyl) lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons.
Topics: Animals; Apoptosis; Culture Techniques; Deoxyglucose; Dose-Response Relationship, Drug; Ganglia, Spinal; Glycation End Products, Advanced; Glyoxal; Guanidines; Lysine; Neurons, Afferent; Rats; Rats, Sprague-Dawley | 1998 |
Accumulation of alpha-oxoaldehydes during oxidative stress: a role in cytotoxicity.
Topics: Animals; Cell Line; Cell Survival; Deoxyglucose; Dinitrochlorobenzene; Glutathione; Glyoxal; Guanidines; Hydrogen Peroxide; Macrophages; Mice; Necrosis; Nitroarginine; Oxidative Stress; Pyruvaldehyde | 1999 |
Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation.
Topics: Animals; Azepines; Cattle; Enzyme Inhibitors; Glycation End Products, Advanced; Glycosylation; Glyoxal; Guanidines; Hypoglycemic Agents; Metformin; Pyruvaldehyde; Serum Albumin | 1999 |
Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions.
Topics: Deoxyglucose; Enzyme Inhibitors; Glyoxal; Guanidines; Kinetics; Pyruvaldehyde; Spectrophotometry; Triazines | 2000 |
Mechanism of the inhibitory effect of OPB-9195 [(+/-)-2-isopropylidenehydrazono-4-oxo-thiazolidin-5-yla cetanilide] on advanced glycation end product and advanced lipoxidation end product formation.
Topics: Aldehydes; Arachidonic Acid; Arginine; Deoxyglucose; Dialysis Solutions; Glycation End Products, Advanced; Glyoxal; Guanidines; Lipid Metabolism; Lysine; Malondialdehyde; Oxidation-Reduction; Peritoneal Dialysis; Prodrugs; Pyruvaldehyde; Thiadiazoles; Thiazolidines | 2000 |
Identification of alpha-dicarbonyl scavengers for cellular protection against carbonyl stress.
Topics: Cells, Cultured; Chelating Agents; Enzyme Inhibitors; Free Radical Scavengers; Glycosylation; Glyoxal; Guanidines; Humans; Keratinocytes; Kinetics; Penicillamine; Pyruvaldehyde | 2002 |
Advanced glycation end product precursors impair epidermal growth factor receptor signaling.
Topics: Cell Line, Transformed; Enzyme Inhibitors; ErbB Receptors; Fibroblasts; Glycation End Products, Advanced; Glyoxal; Guanidines; Humans; Hyperglycemia; Phosphorylation; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Pyruvaldehyde; Signal Transduction; Tyrosine | 2002 |
Peroxynitrite induces formation of N( epsilon )-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite.
Topics: 2-Naphthylamine; Aldehydes; Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Glucose; Glyoxal; Guanidines; Ketoses; Lysine; Mice; Mice, Inbred BALB C; Peroxynitrous Acid; Serum Albumin; Tyrosine | 2002 |
Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection.
Topics: Acetylcysteine; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Dose-Response Relationship, Drug; Female; Glycation End Products, Advanced; Glyoxal; Guanidines; Immunoenzyme Techniques; In Situ Nick-End Labeling; Lysine; Male; Neurons; Niacinamide; Organ Culture Techniques; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Retina; Thioctic Acid; Vanadates | 2003 |
Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis.
Topics: Animals; Aorta; Apolipoproteins E; Arginine; Atherosclerosis; Becaplermin; Cell Movement; Cell Proliferation; Cells, Cultured; Diabetes Complications; Diabetes Mellitus, Experimental; Glycation End Products, Advanced; Glyoxal; Guanidines; Humans; Mesoderm; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-sis; Pyruvaldehyde; Rabbits; Receptor, Platelet-Derived Growth Factor beta | 2007 |
Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: aminoguanidine protection.
Topics: Animals; Cattle; Cell Proliferation; Cells, Cultured; Cytoskeleton; Diabetes Mellitus; Endothelial Cells; Endothelium, Vascular; Glycation End Products, Advanced; Glyoxal; Guanidines; Neovascularization, Physiologic; Nitric Oxide Synthase; Protective Agents | 2010 |
A novel source of methylglyoxal and glyoxal in retina: implications for age-related macular degeneration.
Topics: Cells, Cultured; Chromatography, Liquid; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Glyoxal; Guanidines; Humans; Lipofuscin; Macular Degeneration; Phenylhydrazines; Pyridinium Compounds; Pyruvaldehyde; Retina; Retinal Drusen; Retinaldehyde; Retinoids; Spectrometry, Mass, Electrospray Ionization | 2012 |
In vitro glycation of an endothelialized and innervated tissue-engineered skin to screen anti-AGE molecules.
Topics: Animals; Capillaries; Cattle; Cell Differentiation; Cells, Cultured; Collagen; Cytoskeleton; Dermis; Endothelial Cells; Fibroblasts; Filaggrin Proteins; Glycation End Products, Advanced; Glycosylation; Glyoxal; Guanidines; Humans; Keratinocytes; Lysine; Mice; Neurons; Protective Agents; Skin; Thiazoles; Tissue Engineering | 2015 |
Reactivity, Selectivity, and Reaction Mechanisms of Aminoguanidine, Hydralazine, Pyridoxamine, and Carnosine as Sequestering Agents of Reactive Carbonyl Species: A Comparative Study.
Topics: Aldehydes; Carnosine; Dose-Response Relationship, Drug; Glyoxal; Guanidines; Humans; Hydralazine; Malondialdehyde; Molecular Structure; Pyridoxamine; Pyruvaldehyde; Sequestering Agents; Structure-Activity Relationship | 2016 |